Release Date: 02/10/2014
Lynae M. Brayboy, MD, a third-year fellow in the Division of Reproduction and Infertility at Women & Infants Hospital of Rhode Island, was recently awarded a Physician Scientist Award to participate in the Reproductive Scientist Development Program (RSDP) beginning July 1.
RDSP is a program funded by the National Institutes of Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Launched in 1988, RSDP provides career development support for obstetricians and gynecologists who have completed their clinical training and who are committed to a career of basic science research in an academic setting. The goal is to strengthen the field of obstetrics and gynecology by encouraging the application of contemporary science advances to clinical practice.
Dr. Brayboy’s RSn DP research proposal is entitled “The Role of Multidrug Resistant Transporters in the Protection of the Ovary from Chemotherapy.” Her interests include the study of levels of the HE4 protein in ovulatory women to see if they vary during the menstrual cycle. HE4 is a sensitive serological marker that spikes in certain ovarian and endometrial cancers. To optimize it as a tumor marker that can help diagnose a mass as ovarian or endometrial cancer, researchers need to characterize it in normal menstruation.
About Women & Infants Hospital
Women & Infants and Brown offer fellowship programs in gynecologic oncology, maternal-fetal medicine, urogynecology and reconstructive pelvic surgery, neonatal-perinatal medicine, pediatric and perinatal pathology, gynecologic pathology and cytopathology, and reproductive endocrinology and infertility. It is home to the nation’s first mother-baby perinatal psychiatric partial hospital, as well as the nation’s only fellowship program in obstetric medicine.
Women & Infants has been designated as a Breast Imaging Center of Excellence by the American College of Radiography; a Center of Excellence in Minimally Invasive Gynecology; a Center of Biomedical Research Excellence by the National Institutes of Health (NIH); and a Neonatal Resource Services Center of Excellence. It is one of the largest and most prestigious research facilities in high risk and normal obstetrics, gynecology and newborn pediatrics in the nation, and is a member of the National Cancer Institute’s Gynecologic Oncology Group and the Pelvic Floor Disorders Network.